Latest Pfizer Stories

ROCKLAND, Mass. and NEW YORK, Jan. 3, 2013 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Rebif(®) Rebidose(®) (interferon beta-1a), a single-use auto-injector for the self-administration of Rebif, a disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS). (Logo: http://photos.prnewswire.com/prnh/20130103/SF36310LOGO) (Logo:...

MOUNTAIN VIEW, Calif., Jan. 3, 2013 /PRNewswire/ -- TheraVida, Inc., a clinical-stage biopharmaceutical company developing novel combination drug products, announced positive results from a Phase 2 clinical trial of its lead product candidate Tolenix((TM)) (THVD-201) for the treatment of overactive bladder (OAB) and urge urinary incontinence (UUI). Tolenix((TM)) is a twice-daily (BID) proprietary combination of tolterodine, a muscarinic antagonist used to treat OAB, and pilocarpine,...

SAN FRANCISCO, Jan. 3, 2013 /PRNewswire/ -- Labrys Biologics Inc., a company focused on treatments for chronic migraine, today announced the completion of a $31 Million Series A financing from four leading venture capital firms, venBio, Canaan Partners, InterWest Partners, and Sofinnova Ventures. With the close of the financing, Labrys has acquired RN-307 from Pfizer Inc., a Phase 2 ready anti-CGRP humanized monoclonal antibody for the treatment of chronic migraine. In addition,...

The Site, Which Recently Celebrated its Third Anniversary, Offers People In-Depth Information and Reviews of Anti-Aging Products Miami, Fl (PRWEB) December 28, 2012 HGH10, a website that is devoted to educating people on the latest anti-aging, health and fitness information, has just extended a limited special on the GenF20 platinum package. The current sale features a 6-month supply of GenF20 for $384.99, which is $77 off its usual price. The package also includes three free bonuses: an...

PITTSBURGH, Dec. 28, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Phenytoin Chewable Tablets USP, 50 mg. This product is the generic version of Pfizer's Dilantin® Chewable Tablets, which are indicated for the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor,...

VANCOUVER, British Columbia, Dec. 28, 2012 /PRNewswire/ -- EarningForecast.com has issued consensus earnings forecast reports and equity research for the following companies: Citigroup (NYSE:C), Marvell (NASDAQ:MRVL), Apple (NASDAQ:AAPL), AT&T (NYSE:T), Pfizer (NYSE:PFE), and American International Group (NYSE:AIG). (Logo: http://photos.prnewswire.com/prnh/20121030/HK02457LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to...

VANCOUVER, British Columbia, Dec. 27, 2012 /PRNewswire/ -- Insiderslab.com has issued insider trading reports and equity research for the following companies: Facebook (NASDAQ:FB), Apple (NASDAQ:AAPL), Pfizer (NYSE:PFE), American International Group (NYSE:AIG), Hewlett-Packard (NYSE:HPQ), and Wells Fargo (NYSE:WFC). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your...

NEWARK, Calif., Dec. 26, 2012 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that its lawsuits against two filers of Abbreviated New Drug Applications (ANDAs) for Gralise(®) (gabapentin) have been dismissed. Watson Laboratories has withdrawn its Gralise ANDA. Par Pharmaceutical has amended its Gralise ANDA and is no longer seeking approval of the ANDA prior to the expiration of Depomed's patents listed for Gralise in the FDA publication commonly known as the Orange...

HGH advanced #1 rated natural hormone booster is now available for purchase with a new improved formula for more effective results Los Angeles, California, USA (PRWEB) December 24, 2012 HGH advanced is the #1 Rated growth hormone releaser clinically proved and FDA registered growth hormone booster formulate with all organic substances to help people naturally reducing aging signs. This supplement is now available for online purchase with a new improved formula that is more effective than...

NEW YORK, Dec. 21, 2012 /PRNewswire/ -- If you've been trying in vain to find the new growth hormone-boosting formula everyone's been talking about, you can blame the popular media. The cutting-edge research behind the formula was recently featured on one of daytime television's hottest programs. This segment created a firestorm of demand for the proprietary amino acid compound developed by Sierra Research Labs(TM), and now the company is having to take steps to end the vast...